THE SIMMONS & RUSSELL GROUP, LLC for ELI LILLY AND COMPANY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the pharmaceutical industry including healthcare policy, drug pricing, drug value, insulin, and the 340B Program. Monitoring implementation of the Inflation Reduction Act of 2022, H.R.5376, P.L.117-169. Monitoring implementation of the Infrastructure Investment and Jobs Act, H.R.3684, P.L.117-58. Issues related to obesity reduction. Issues related to Alzheimers coverage and access. Issues related to PBM reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Taxation/Internal Revenue Code TAX
Issues related to tax legislation; Tax Relief for American Families and Workers Act of 2024, H.R.7024.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.